Considerations To Know About Sifalimumab
The primary end position was the security and tolerability of sifalimumab. Therapy-emergent adverse events (AEs) and critical AEs (SAEs) as well as their severity, outcome, and any connection for the research medication ended up recorded from the investigator all over the study. AEs had been deemed prone to be related to review medication if they h